tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Income Statement

Compare
1 Followers

Keymed Biosciences, Inc. Income Statement

Last quarter (Q4 2024), Keymed Biosciences, Inc.'s total revenue was ¥373.44M, an increase of 592665.08% from the same quarter last year. In Q4, Keymed Biosciences, Inc.'s net income was ¥-178.50M. See Keymed Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 428.12M¥ 354.10M¥ 100.06M¥ 110.27M¥ 0.00
Gross Profit
¥ 415.92M¥ 317.22M¥ 97.48M¥ 93.07M¥ 0.00
Operating Expenses
¥ 1.00B¥ 752.02M¥ 575.74M¥ 442.89M¥ 135.47M
Depreciation and Amortization
¥ 51.63M¥ 69.16M¥ 36.12M¥ 21.02M¥ 13.89M
EBITDA
¥ -574.46M¥ -269.77M¥ -259.25M¥ -3.86B¥ -785.71M
Operating Income
¥ -618.10M¥ -434.80M¥ -295.38M¥ -3.88B¥ -804.70M
Other Income/Expenses
¥ 109.45M¥ 78.61M¥ -8.22M¥ -3.52B¥ -669.90M
Pretax Income
¥ -508.65M¥ -356.19M¥ -303.60M¥ -3.89B¥ -818.85M
Net Income
¥ -515.24M¥ -359.36M¥ -308.12M¥ -3.90B¥ -832.73M
Per Share Metrics
Basic EPS
¥ -1.97¥ -1.37¥ -1.18¥ -24.24¥ -3.07
Diluted EPS
¥ -1.97¥ -1.37¥ -1.18¥ -24.24¥ -3.07
Weighted Average Shares Outstanding
261.95M 261.37M 261.13M 160.85M 271.00M
Weighted Average Shares Outstanding (Diluted)
261.95M 261.37M 261.13M 160.85M 271.00M
Currency in CNY

Keymed Biosciences, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis